Clinical Trial Update: Extended-release Buprenorphine as a Novel Low-dose Induction Strategy [Phase 2]

View source ↗

Summary

A Phase 2 trial from Brigham and Women's Hospital is evaluating extended-release buprenorphine as a novel low-dose induction strategy for opioid use disorder an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING